Cannabis 1933 strengthens balance sheet, but revenue cut by Covid The company has cut back on operating expenses in an effort to weather the current economic storm Nick LabaJune 29, 2020
Analysis MediPharm watches revenues fall 65% Extractor also reports $12.8 million write-down due to glut of Canadian cannabis concentrates Jared GnamJune 18, 2020
The weed wire WeedMD bullish despite reporting $2.8M in Q4 sales Company says it planted 18,000 clones outdoors, predicts Q1 revenue will jump to $12 million Jared GnamJune 12, 2020
Analysis Hexo says profits depend on more pot shop openings in Ontario, Quebec Shares of Hexo slipped another 5% after reporting a third-quarter net loss of $19.5 million Jared GnamJune 11, 2020
COVID-19 Auxly says record $10 million Q1 net revenue driven by cannabis 2.0 sales Company says infused candies and vapes made up 90% of first-quarter Canadian weed sales Jared GnamJune 1, 2020
Cannabis 2.0 Canopy Growth shares sink after reporting another billion-dollar loss Company stock drops 20%, throws out previous profit targets for fiscal 2021 Jared GnamMay 29, 2020
The weed wire TGOD falls on low revenues, introduces 28-gram value brand Company books $660K in Canadian weed sales with a net loss of $73.4 million in Q1 Jared GnamMay 27, 2020
COVID-19 Curaleaf says it’s on track to be world’s biggest weed company in Q1 report Company says it will have 100 dispensaries operating in 22 US states by end of year Jared GnamMay 19, 2020
COVID-19 Green Thumb becomes first US weed firm to hit $100M in quarterly revenue Chicago-based MSO rang in US$102.6 million in first-quarter net revenues Jared GnamMay 14, 2020
Canada Cronos continues to underwhelm in Q1, warns COVID-19 will hamper sales CEO Mike Gorenstein forecasts a 'bumpy' road ahead for Canada's weed industry Jared GnamMay 8, 2020